Modification of cystatin C activity by bacterial proteinases and neutrophil elastase in periodontitis

Journal of Clinical Pathology - Molecular Pathology

Volumn 50, Issue 6, 1997, Pages 291-297

  Abrahamson, Magnus ^a   Wikström, Maude ^b   Potempa, Jan ^c,d   Renvert, Stefan ^e   Hall, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c JAGIELLONIAN UNIVERSITY   (Poland)

^d UNIVERSITY OF GEORGIA   (United States)

^e Public Dental Health Service   (Sweden)

Author keywords

Actinobacillus actinomycetemcomitans; Cathepsin B; Cysteine proteinase inhibitor; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia

Indexed keywords

BACTERIAL ENZYME; CYSTATIN C; LEUKOCYTE ELASTASE; PROTEINASE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ARTICLE; BACTERIAL METABOLISM; ENZYME ACTIVITY; HUMAN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PRIORITY JOURNAL;

EID: 0031441656     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.50.6.291     Document Type: Article

References (56)

1. Grubb A, Lötberg H. Human gamma-trace, a basic microprotein: amino acid sequence and presence in the adenohypophysis. Proc Natl Acad Sci USA 1982;79:3024-7.
2. Abrahamson M, Grubb A, Olafsson I, Lundwall A. Molecular cloning and sequence analysis of cDNA coding for the precursor of the human cysteine proteinase inhibitor cystatin C. FEBS Lett 1987;216:229-33.
3. Barrett AJ, Davies ME, Grubb A. The place of human γ-trace (cystatin C) amongst the cysteine proteinase inhibitors. Biochem Biophys Res Commun 1984;120:631-6.
4. Brömme D, Rinne R, Kirschke H. Tight-binding inhibition of cathepsin S by cystatins. Biochem Biochim Acta 1991;50: 631-5.
5. Abrahamson M, Ritonja A, Brown MA, Grubb A, Machleidt W, Barrett AJ. Identification of the probable inhibitory reactive sites of the cysteine proteinase inhibitors human cystatin C and chicken cystatin. J Biol Chem 1987; 262:9688-94.
6. Abrahamson M, Mason RW, Hansson H, Buttle DJ, Grubb A, Ohlsson R. Human cystatin C: role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J 1991;273:621-6.
7. Hall A, Dalboge H, Grubb A, Abrahamson M. Importance of the evolutionary conserved glycine residue in the N-termmal region of cystatin C (Gly-11) for cysteine endopeptidase inhibition. Biochem J 1993;291:123-9.
8. Hall A, Hakansson K, Mason RW, Grubb A, Abrahamson M. Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases. J Biol Chem 1995;270: 5115-21.
9. Bode W, Engh R, Musil D, Thiele U, Huber R, Karshikov A, et al. The 2.0 A X-ray crystal structure of chicken egg white cystatin and its possible mode of interaction with cysteine proteinases. EMBO J 1988;7:2593-9.
10. Ekiel I, Abrahamson M, Fulton DB, Lindahl P, Storer AC, Levadoux W, et al. NMR structural studies of human cystatin C dimers and monomers. J Mol Biol 1997;271: 266-77.
11. Abrahamson M, Salvesen G, Barrett AJ, Grubb A. Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. J Biol Chem 1986;261: 11282-9.
12. Assfalg-Machleidt I, Jochum M, Klaubert W, Inthorn D, Machleidt W. Enzymatically active cathepsin B dissociating from its inhibitor complexes is elevated in blood plasma of patients with septic shock and some malignant tumors. Biol Chem Hoppe-Seyler 1988;369(suppl):263-9.
13. Köppel P, Baici A, Keist R, Matzku S, Keller R. Cathepsin B-like proteinase as a marker for metastatic tumor cell variants. Exp Cell Biol 1984;52:293-9.
14. Gabrijelcic D, Annan-Prah A, Rodic B, Rozman B, Cotic V, Turk V. Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases. J Clin Chem Clin Bichem 1990;28:149-53.
15. Buttle DJ, Burnett D, Abrahamson M. Levels of neutrophil elastase and cathepsin B activities, and cystatins in human sputum: relationship to inflammation. Scand J Clin Lab Invest 1990;50:509-16.
16. Cox SW, Eley BM. Detection of cathepsin B- and L-, elastase-, tryptase-, trypsin-, and dipeptidyl peptidase IV-like activities in crevicular fluid from gingivitis and periodontitis patients with peptidyl derivatives of 7-amino-4-trifluoromethyl coumarin. J Periodont Res 1989;24:353-61.
17. Björck L, Akesson P, Bohus M, Trojnar J, Abrahamson M, Olafsson I, et al. Bacterial growth inhibited by a synthetic inhibitor based upon the structure of a human proteinase inhibitor. Nature 1989;337:385-6.
18. Potempa J, Dubin A, Korzus G, Travis J. Degradation of elastin by a cysteine proteinase from Staphylococcus aureus. J Biol Chem 1988;263:2664-7.
19. Siffert O, Emöd I, Keil B. Interaction of clostripain with natural trypsin inhibitors and its affinity labeling by Na-p-nitrobenzyloxycarbonyl arginine chlormethyl ketone. FEBS Lett 1976;66:114-19.
20. Slots J, Bragd L, Wikström M, Dahlén G. The occurrence of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius in destructive periodontal disease in adults. J Clin Periodontol 1986;13:570-7.
21. Travis J, Pike R, Imamura T, Potempa J. Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J Periodontal Res 1997;32:120-5.
22. Birkedal-Hansen H, Taylor RE, Zambon JJ, Barw PK, Neiders ME. Characterization of collagenolytic activity from strains of Bacteroides gingivalis. J Periondont Res 1988; 23:258-64.
23. Hinode D, Nagata A, Ichimiya, S, Hayashi H, Morioka M, Nakamura R. Generation of plasma kinin by three types of protease generated from Porphyromonas gingivalis 381. Arch Oral Biol 1992;37:859-61.
24. Chen Z, Potempa J, Polanowski A, Wikström M, Travis J. Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J Biol Chem 1992;267:18890-901.
25. Pike R, McGraw W, Potempa J, Travis J. Lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Isolation, characterization, and evidence for the existence of complexes with hemagglutinins. J Biol Chem 1994;269:406-11.
26. Pavloff N, Potempa J, Pike RN, Prochazka V, Kiefer MC, Travis J, et al. Molecular cloning and characterization of Porphyromonas gingivalis lysine-specific gingipain. A new member of an emerging family of pathogenic bacterial cysteine proteinases. J Biol Chem 1995;270:1007-10.
27. Potempa J, Pike R, Travis J. The multiple forms of trypsin-like activity present in various strains of Porphyromonas gingivalis are due to the presence of either Arg-gingipain or Lys-gingipain. Infect Immun 1995;63:1176-82.
28. Abrahamson M, Dalbøge H, Olafsson I, Carlsen S, Grubb A. Efficient production of native, biologically active human cystatin C by Escherichia coli. FEBS Lett 1988;236:14-8.
29. Rich DH, Brown MA, Barrett AJ. Purification of cathepsin B by a new form of affinity chromatography. Biochem J 1986;235:731-4.
30. Blumberg A, Schechter I, Berger A. The purification of papain by affinity chromatography. Eur J Biochem 1970;15: 97-102.
31. Jeppsson J-O, Laurell C-B, Franzén B. Agarose gel electrophoresis. Clin Chem 1979;25:629-38.
32. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
33. Matsudaira P. Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 1987;262:10035-8.
34. Olafsson I, Gudmundsson G, Abrahamson M, Jensson O, Grubb A. The aminoterminal portion of cerebrospinal fluid cystatin C in hereditary cystatin C amyloid angiopathy is not truncated. Direct sequence analysis from agarose gel electropherograms. Scand J Clin Lab Invest 1990;50:85-93.
35. Lindahl P, Abrahamson M, Björk I. Interaction of recombinant human cystatin C with the cysteine proteinases papain and actinidin. Biochem J 1992;281:40-55.
36. Renvert S, Wikström M, Dahlén G, Slots J, Egelberg J. On the inability of root debridement and periodontal surgery to eliminate Actinobacillus actinomycetemcomitans from periodontal pockets. J Clin Periodontol 1990;17:351-5.
37. Olafsson I, Löfberg H, Abrahamson M, Grubb A. Production, characterization and use of monoclonal antibodies against the major extracellular human cysteine proteinase inhibitors cystatin C and kininogen. Scand J Clin Lab Invest 1988;48:573-82.
38. Wikström MB. Detection of microbial proteolytic activity by a cultivation plate assay in which different proteins adsorbed to a hydrophobic surface are used as substrates. Appl Environ Microbiol 1983;45:393-400.
39. Johansson BG. Agarose gel electrophoresis. Scand J Clin Lab Invest 1972;29(suppl 124):7-19.
40. Barrett AJ, Kembhavi AA, Brown MA, Kirschke H, Knight CG, Tamai M, et al. L-trans-epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J 1982;201:189-98.
41. Abrahamson M. Cystatins. Methods Enzymol 1994;244:685-700.
42. Wikström M, Potempa J, Polanowski A, Travis J, Renvert S. Detection of Porphyromonas gingivalis in gingival exudate by a dipeptide-enhanced trypsin-like activity. J Periodontol 1994;65:47-55.
43. Hall A, Abrahamson M, Grubb A, Trojnar J, Kania P, Kasprzykowska R, et al. Cystatin C based peptidyl diazomethanes as cysteine proteinase inhibitors: Influence of the peptidyl chain length. J Enzyme Inhib 1992;6:113-23.
44. Bieth JG. Pathophysiological interpretation of kinetic constants of protease inhibitors. Bull Eur Physiopath Resp 1980;16(suppl):183-95.
45. Bourgeau G, Laipointe H, Peloquin P, Mayrand D. Cloning, expression, and sequencing of a protease gene (tpr) from Porphyromonas gingivalis W83 in Escherichia coli. Infect Immun 1992;60:3186-92.
46. Madden TE, Clark VL, Kuramitsu HK. Revised sequence of the Porphyromonas gingivalis prtT cysteine protease hemagglutiinn gene: homology with streptococcal pyrogenic exotoxin B streptococcal proteinase. Infect Immun 1995;63:238-47.
47. Kilian M. Degradation of immunoglobulins A2, A2, and G by suspected principal periodontal pathogens. Infect Immun 1981;34:757-65.
48. Wikström M, Linde A. Ability of oral bacteria to degrade fibronectin. Infect Immun 1986;51:707-11.
49. Carlsson J, Höfling JF, Sundqvist GK. Degradation of albumin, haemopexin, haptoglobin and transferrin, by black-pigmented Bacteroides species. J Med Microbiol 1984;18: 30-46.
50. Ichimaru E, Imura K, Hara Y, Kato I. Cystatin activity in gingival crevicular fluid from periodontal disease patients measured by a new quantitative analysis method. J Periodont Res 1992;27:110-25.
51. Ohlsson K, Olsson I, Tynelius-Bratthall G. Neutrophil leukocyte collagenase, elastase and serum protease inhibitors in human gingival crevicles. Acta Odontol Scand 1974;31: 51-9.
52. 1-antitrypsin in periodontal health and disease. Arch Oral Biol 1994:39:301-6.
53. Lah T, Skaleric U, Babnik J, Turk V. Detection of cathepsin L-like proteinase and cathepsin D in gingival fluid. J Periodont Res 1086;21:504-9.
54. Kennett CN, Cox SW, Eley BM. Comparative histochemical, biochemical and immunocytochemical studies of cathepsin B in human gingiva. J Periodont Res 1994;29:203-13.
55. Delaissé J-M, Eeckout Y, Vaes G. In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem Biophys Res Commun 1984;125: 441-7.
56. Rifkin BR, Vernillo A, Kleckner AP, Auszmann J, Rosenberg L, Zimmerman M. Cathepsin B and L activities in isolated osteoclasts. Biochem Biophys Res Commun 1991;179:63-9.